Hazard
1,563 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 1,563 cgmp deviation recalls we have scored against our rubric, 1 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 288 (18%) are Severe.
Which agencies issued them
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all cgmp deviation recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Baxter Healthcare is voluntarily recalling specific lots of Daptomycin Injection due to Current Good Manufacturing Practice (CGMP) deviations. The recall covers the US, Puerto Rico, and Chile.
Baxter Healthcare is voluntarily recalling Daptomycin in Sodium Chloride Injection due to Current Good Manufacturing Practice (CGMP) deviations.
Baxter Healthcare is voluntarily recalling specific lots of Vasopressin in 0.9% Sodium Chloride Injection due to Current Good Manufacturing Practice (CGMP) deviations.
Baxter Healthcare is voluntarily recalling specific lots of Vancomycin Injection due to Current Good Manufacturing Practice (CGMP) deviations.
Baxter Healthcare is voluntarily recalling specific lots of Clindamycin Injection due to CGMP deviations. The affected product was distributed in the US, Puerto Rico, and Chile.
Baxter Healthcare is voluntarily recalling specific lots of Clindamycin Injection due to Current Good Manufacturing Practice (CGMP) deviations.
Baxter Healthcare is voluntarily recalling specific lots of CARDENE IV (Nicardipine Hydrochloride) injection due to CGMP deviations. The recall covers products distributed in the US, Puerto Rico, and Chile.
Baxter Healthcare is voluntarily recalling specific lots of Clindamycin Injection due to Current Good Manufacturing Practice (CGMP) deviations.
Baxter Healthcare is voluntarily recalling MYXREDLIN insulin due to CGMP deviations. The recall covers specific lots distributed in the US, Puerto Rico, and Chile.
Baxter Healthcare is voluntarily recalling Clindamycin Phosphate Injection due to Current Good Manufacturing Practice (CGMP) deviations. The affected product was distributed in the US, Puerto Rico, and Chile.
Lexia LLC is recalling Broadway Joe's Pain Cream in Colorado due to CGMP deviations and potential raw material contamination.
Church & Dwight is recalling Zicam Cold Remedy Nasal Swabs because FDA inspections found out-of-limit microbiological testing results at the contract manufacturer.
Golden State Medical Supply is recalling 1,200 bottles of Carbamazepine 200mg tablets due to tablets containing black specks.
Shoolin Pharma Chem LLP is recalling Tadalafil USP 1.00 KG bags due to Current Good Manufacturing Practice (CGMP) deviations noted during an FDA inspection.
Shoolin Pharma Chem LLP is recalling Tadalafil USP 0.500 KG bags due to Current Good Manufacturing Practice (CGMP) deviations noted during an FDA inspection.
Shoolin Pharma Chem LLP is recalling Tadalafil USP 0.100 KG bags due to Current Good Manufacturing Practice (CGMP) deviations noted during an FDA inspection.
Shoolin Pharma Chem LLP is recalling Sildenafil Citrate USP due to Current Good Manufacturing Practice (CGMP) deviations identified during an FDA inspection.
Shoolin Pharma Chem LLP is recalling Sildenafil Citrate USP 1.00KG bags due to CGMP deviations noted during an FDA inspection.
Shimoga Chemicals is voluntarily recalling Clomiphene Citrate USP active pharmaceutical ingredient in three package sizes due to current good manufacturing practice (cGMP) deviations. The product was distributed in California and Florida.
Lupin Pharmaceuticals is recalling Glucagon Emergency Kits (1mg) nationwide due to a manufacturing process deviation found during stability testing. The gliding force functionality test failed to meet specifications during 12-month testing.
Blaine Labs Inc is recalling Terpenicol (Undecylenic Acid) antifungal solution because the firm discontinued required stability testing for products still on the market within their expiration dates.
Blaine Labs Inc is recalling Tridergel wound care gel nationwide due to current good manufacturing practice (CGMP) deviations. The product was manufactured in a facility under the same conditions as contaminated product.
Blaine Labs Inc is recalling TERPENICOL Antifungal Cream due to CGMP deviations: the firm discontinued required stability testing for products still within expiry dates. The recall affects 22,143 bottles distributed nationwide.
Blaine Labs Inc is recalling Fungal Fusion ERADICATION Solution kits nationwide because the manufacturer discontinued required stability testing for products still on the market within their expiration dates.
Blaine Labs Inc is recalling TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%) because the firm discontinued required stability testing for products still on the market within their expiration date.